FDA Approves New PARP Inhibitor for BRCA-mutant Ovarian Cancer
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
Tag: Ovarian cancer
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
New imaging system can help surgeons get more cancer out; Presurgery chemo can make ovarian cancer responsive to immunotherapy...
The past year brought some progress, which the American Association for Cancer Research highlighted in a guest article for...
Guest Post by Roswell Park Cancer Institute Department of Public Affairs
Guest Post by Alan D. D’Andrea, MD, and Elizabeth M. Swisher, MD SU2C-OCRF-OCNA-NOCC Dream Team
Laura Shawver, PhD, is working to change the game for ovarian cancer.
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
Last week, more than 100 patients, survivors, family members, advocates, and researchers came together for a symposium at the...
In the coming months, we will share posts from advocates who participated in the AACR’s Scientist↔Survivor Program at the...